Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

774.61
+0.50000.06%
Post-market: 774.60-0.01000.00%18:38 EDT
Volume:382.87K
Turnover:296.99M
Market Cap:79.75B
PE:19.16
High:779.98
Open:775.82
Low:771.80
Close:774.11
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.70
T/O Rate:0.39%
Dividend:3.64
Dividend Rate:0.47%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.51
PE(LYR):18.67

Loading ...

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 08

Regeneron Director Arthur F. Ryan Sells 200 Shares Worth $130,030

Reuters
·
Jul 08

Regeneron Pharma is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Jul 07

Movement Alert|Regeneron Pharmaceuticals Rises 3.06% in Regular Trading, Selected for FDA Accelerated New Production Facility Review Program

Market Focus
·
Jul 07

Regeneron price target lowered to $769 from $778 at Truist

TIPRANKS
·
Jul 07

RBC Capital Adjusts Regeneron Pharmaceuticals Price Target to $696 From $707, Maintains Sector Perform Rating

MT Newswires Live
·
Jul 07

Regeneron Pharmaceuticals Inc : Truist Securities Cuts Target Price to $769 from $778

THOMSON REUTERS
·
Jul 07

Regeneron Pharma is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Jul 06

HSBC Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $990

MT Newswires Live
·
Jul 06

Regeneron price target lowered to $750 from $785 at Cantor Fitzgerald

TIPRANKS
·
Jul 06

Regeneron Pharmaceuticals - Expects Q2 2026 Bought Ipr&d Charge of $127 Mln Pre-tax - SEC Filing

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals - Expects Q2 2026 Gaap and Non-gaap Net Income Per Diluted Share to Decrease by $1 - SEC Filing

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals Inc Q2 Shr View $10.81

THOMSON REUTERS
·
Jul 06

U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial

Reuters
·
Jul 06

Eli Lilly, Regeneron Among First Companies Selected for FDA Initiative to Speed Review of New Manufacturing Facilities - CNBC

Reuters
·
Jul 06

Regeneron Pharmaceuticals Inc : HSBC Cuts Target Price to $800 from $990

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 03

Movement Alert|Regeneron Pharmaceuticals Rises 3.1% in Regular Trading, Selected for FDA Production Pilot Plus Priority Review for Novel Drug

Market Focus
·
Jul 02

Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)

TIPRANKS
·
Jul 01

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 01